These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 24259296)
1. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. Raber PL; Thevenot P; Sierra R; Wyczechowska D; Halle D; Ramirez ME; Ochoa AC; Fletcher M; Velasco C; Wilk A; Reiss K; Rodriguez PC Int J Cancer; 2014 Jun; 134(12):2853-64. PubMed ID: 24259296 [TBL] [Abstract][Full Text] [Related]
2. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events. Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002 [TBL] [Abstract][Full Text] [Related]
3. Modulation of CD8(+) T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells. Schouppe E; Van Overmeire E; Laoui D; Keirsse J; Van Ginderachter JA Immunobiology; 2013 Nov; 218(11):1385-91. PubMed ID: 23932436 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells. Nagatani Y; Funakoshi Y; Suto H; Imamura Y; Toyoda M; Kiyota N; Yamashita K; Minami H J Cancer Res Ther; 2021; 17(4):1093-1100. PubMed ID: 34528569 [TBL] [Abstract][Full Text] [Related]
5. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. Jayaraman P; Parikh F; Lopez-Rivera E; Hailemichael Y; Clark A; Ma G; Cannan D; Ramacher M; Kato M; Overwijk WW; Chen SH; Umansky VY; Sikora AG J Immunol; 2012 Jun; 188(11):5365-76. PubMed ID: 22529296 [TBL] [Abstract][Full Text] [Related]
6. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565 [TBL] [Abstract][Full Text] [Related]
7. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. Youn JI; Nagaraj S; Collazo M; Gabrilovich DI J Immunol; 2008 Oct; 181(8):5791-802. PubMed ID: 18832739 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive Myeloid Cells Induce Nitric Oxide-Dependent DNA Damage and p53 Pathway Activation in CD8 Cartwright ANR; Suo S; Badrinath S; Kumar S; Melms J; Luoma A; Bagati A; Saadatpour A; Izar B; Yuan GC; Wucherpfennig KW Cancer Immunol Res; 2021 Apr; 9(4):470-485. PubMed ID: 33514509 [TBL] [Abstract][Full Text] [Related]
9. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Xu J; Xie Z; Reece R; Pimental D; Zou MH Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2688-95. PubMed ID: 17023679 [TBL] [Abstract][Full Text] [Related]
10. Granulocytic myeloid-derived suppressor cells from human cord blood modulate T-helper cell response towards an anti-inflammatory phenotype. Köstlin N; Vogelmann M; Spring B; Schwarz J; Feucht J; Härtel C; Orlikowsky TW; Poets CF; Gille C Immunology; 2017 Sep; 152(1):89-101. PubMed ID: 28464218 [TBL] [Abstract][Full Text] [Related]
11. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis. Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167 [TBL] [Abstract][Full Text] [Related]
17. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Movahedi K; Guilliams M; Van den Bossche J; Van den Bergh R; Gysemans C; Beschin A; De Baetselier P; Van Ginderachter JA Blood; 2008 Apr; 111(8):4233-44. PubMed ID: 18272812 [TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration. Xu J; Luo Y; Yuan C; Han L; Wu Q; Xu L; Gao Y; Sun Y; Ma S; Tang G; Li S; Sun W; Gong Y; Xie C Int J Biol Sci; 2020; 16(9):1563-1574. PubMed ID: 32226302 [TBL] [Abstract][Full Text] [Related]
20. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]